Home3696 • HKG
add
Insilico Medicine Cayman TopCo
Nakaraang pagsara
$57.95
Sakop ng araw
$54.30 - $59.50
Sakop ng taon
$29.98 - $59.85
Market cap
30.74B HKD
Average na Volume
3.00M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.73M | -54.00% |
Gastos sa pagpapatakbo | 22.69M | -14.83% |
Net na kita | -9.61M | -339.29% |
Net profit margin | -69.98 | -620.30% |
Kita sa bawat share | — | — |
EBITDA | -10.57M | -555.35% |
Aktuwal na % ng binabayarang buwis | -0.21% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 212.63M | — |
Kabuuang asset | 241.31M | — |
Kabuuang sagutin | 922.68M | — |
Kabuuang equity | -681.36M | — |
Natitirang share | 77.27M | — |
Presyo para makapag-book | -6.57 | — |
Return on assets | -11.58% | — |
Return on capital | 4.14% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -9.61M | -339.29% |
Cash mula sa mga operasyon | -18.42M | -13.79% |
Cash mula sa pag-invest | 1.20M | 128.40% |
Cash mula sa financing | 60.19M | 13,718.44% |
Net change in cash | 43.09M | 308.18% |
Malayang cash flow | -4.80M | — |
Tungkol
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
Itinatag
2014
Website
